About
Fyodor Urnov is a genome-editing scientist and professor at the University of California, Berkeley, where he serves as Director of Therapeutic R&D at the Innovative Genomics Institute. He is a co-founder of Tune Therapeutics and, as of January 9, 2026, was also publicly named a founder of Aurora Therapeutics. His work centers on CRISPR, epigenome editing, and expanding access to genetic medicines for rare and pediatric diseases.
Areas of interest
biotechgenome editingepigenome editingCRISPR therapeuticscell and gene therapyrare diseasetranslational genomicspediatric genetic diseaseinfectious diseaseaffordable genetic medicines